Takeda Pharmaceutical Company Limited (TYO: 4502)
Japan
· Delayed Price · Currency is JPY 4,038.00
+6.00 (0.15%)
Jan 21, 2025, 3:30 PM JST
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 49,281 employees as of March 31, 2024. The number of employees increased by 186 or 0.38% compared to the previous year.
Employees
49,281
Change (1Y)
186
Growth (1Y)
0.38%
Revenue / Employee
92.25M JPY
Profits / Employee
5.88M JPY
Market Cap
6,400.96B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Chugai Pharmaceutical | 7,604 |
| Daiichi Sankyo Company | 18,726 |
| HOYA Corporation | 35,702 |
| Otsuka Holdings | 34,388 |
| Astellas Pharma | 14,754 |
| Olympus | 28,838 |
| Shionogi & | 4,959 |
| Sysmex | 10,042 |
Takeda Pharmaceutical Company News
- 16 hours ago - Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO - Reuters
- 25 days ago - Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency - Benzinga
- 25 days ago - Takeda Pharmaceutical Co Ltd (TAK) Secures Approval for HYQVIA in Japan - GuruFocus
- 25 days ago - Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia - Benzinga
- 25 days ago - Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia - Business Wire
- 5 weeks ago - Takeda Pharmaceutical Co Ltd (TAK) Unveils Promising Late-Stage Pipeline at Investor R&D Day - GuruFocus
- 5 weeks ago - Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas - Business Wire
- 6 weeks ago - Takeda Pharmaceutical: Dividend Yield Is High But Hides Pitfalls Especially For US Investors - Seeking Alpha